Laser treatment of pigmented lesions-2000: How far have we gone?

Archives of Dermatology

Volumn 136, Issue 7, 2000, Pages 915-921

  Stratigos, Alexander J ^a   Dover, Jeffrey S ^b   Arndt, Kenneth A ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SkinCare Physicians of Chestnut Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID NITROGEN; MINOCYCLINE;

CLINICAL TRIAL; CRYOTHERAPY; HUMAN; LASER SURGERY; LENTIGO; MELANOCYTIC NEVUS; PATIENT SATISFACTION; PIGMENT DISORDER; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; TREATMENT OUTCOME;

HUMANS; LASERS; NEVUS, PIGMENTED; PIGMENTATION DISORDERS; SKIN NEOPLASMS;

EID: 0033868070     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Stern RS, Dover JS, Levin J, Arndt KA. Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol. 1994;30:985-987.
2. Li YT, Yang KC. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999;25:202-204.
3. Todd MM, Rallis TM,Gerwels JW, Hata TR. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol. 2000; 136:841-846.
4. Goldman L, Blaney DJ, Kindel DJ, Franke EK. Effect of the laser beam on the skin: preliminary report. J Invest Dermatol. 1963;40:121-122.
5. Goldman L, Wilson RG, Hornby P, et al. Radiation from a Q-switched ruby laser. J Invest Dermatol. 1965;44:69-71.
6. Apfelberg DB, Maser MR, Lash H, Rivers JL. Progress report on extended clinical use of the argon laser for cutaneous lesions. Lasers Surg Med. 1980;1:71-83.
7. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.
8. Anderson RR, Parrisn JA. The optics of human skin. J Invest Dermatol. 1981;77:13-19.
9. Polla LL, Margolis RJ, Dover JS, et al. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol. 1987;89:281-286.
10. Dover JS, Polla LL, Margolis RJ, et al. Pulse width dependence of pigment cell damage at 694 nm in guinea pig skin. SPIE Lasers Med. 1986;712: 200-205.
11. Watanabe S, Flotte T, Margolis R, et al. The effects of pulse duration on selective pigmented cell injury by dye lasers. J Invest Dermatol. 1987;88: 523.
12. Anderson RR, Margolis RJ, Watanabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989;93:28-32.
13. Sherwood K, Murray S, Kurban A, Tan O. Effect of wavelength of cutaneous pigment using pulsed irradiation. J Invest Dermatol. 1989;92:717-720.
14. Margolis R, Dover J, Polla L, et al. Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med. 1989;9:389-397.
15. Ara G, Anderson RR, Mandel KG, Otteson M, Oseroff AR. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells. Lasers Surg Med. 1990;10:52-59.
16. Ort RJ. Tattoos and their treatments. Med Surg Dermatol. 1998;5:265-268.
17. Taylor CR, Anderson RR, Gange RW, Michaud NA, Flotte TJ. Light and electron microscopic analysis of tattoos treated by Q-switched ruby laser. J Invest Dermatol. 1991;97:131-136.
18. Herd RM, Alora MB, Smoller B, Arndt KA, Dover JS. A clinical and histologic prospective controlled comparative study of the picosecond titanium: sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol. 1999;40: 603-606.
19. Dover JS, Margolis RJ, Polla LL, et al. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses: morphologic and histologic findings. Arch Dermatol. 1989;125: 43-49.
20. Hruza GJ, Dover JS, Flotte T, Goetschkes M, Watanabe S, Anderson RR. Q-switctied ruby laser irradiation of normal human skin: histologic and ultrastructural findings. Arch Dermatol. 1991;127: 1799-1805.
21. Gold MH, Foster TD, Bell MW. Nevus spilus successfully treated with an intense pulsed light source. Dermatol Surg. 1999;25:254-255.
22. Grossman MC, Dierickx C, Farinelli W, Flotte T, Anderson RR. Damage to hair follicles by normal-mode ruby laser pulses. J Am Acad Dermatol. 1996;35:889-894.
23. Ueda S, Imayama S. Normal-mode ruby laser for treating congenital nevi. Arch Dermatol. 1997; 133:355-359.
24. Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300-nanosecond pulse and a 510-nm wavelength. J Dermatol Surg Oncol. 1993;18: 341-347.
25. Goldberg DJ. Benign pigmented lesions of the skin: treatment with the Q-switched ruby laser. J Dermatol Surg Oncol. 1993;19:376-379.
26. Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd: YAG laser: a controlled, single-impact, dose-response, multicenter trial. Arch Dermatol. 1994; 130:1515-1519.
27. Grevelink JM, Casparian JM, Gonzalez E, et al. Undesirable side effects associated with treatment of tattoos and pigmented lesions with Q-switched lasers at 1064 nm and 694 nm: the MGH experience [abstract]. Lasers Surg Med Suppl. 1993;5:53.
28. Grossman MC, Anderson RR, Farinelli W, Flotte TJ, Grevelink JM. Treatment of café au lait macules with lasers: a clinicopathologic correlation. Arch Dermatol. 1995;131:1416-1420.
29. Alster TS. Complete elimination of large café-au-lait birthmarks by 510-nm pulsed dye laser. Plast Reconstr Surg. 1995;96:1660-1664.
30. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and post-inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20:592-597.
31. Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121-123.
32. 2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999; 25:494-497.
33. Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med. 1994;331:1745-1750.
34. Apfelberg DB, Argon and Q-switched yttrium-aluminum-garnet laser treatment of nevus of Ota. Ann Plast Surg. 1995;35:150-153.
35. Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg. 1995;21:592-596.
36. Geronemus RG. Q-switched laser therapy of nevus of Ota. Arch Dermatol. 1992;128:1618-1622.
37. Ueda S, Isoda M, Imayama S. Response of naevus of Ota to Q-switched ruby laser treatment according to lesion colour. Br J Dermatol. 2000; 142:77-83.
38. Kang W, Lee E, Choi GS. Treatment of Ota's nevus by Q-switched alexandrite laser: therapeutic outcome in relation to clinical and histopathologic findings. Eur J Dermatol. 1999;9:639-643.
39. Watanabe S, Anderson RR, Brorson S, Dalickas G. Fujimoto JG, Flotte TJ. Comparative studies of femtosecond to microsecond laser pulses on selective pigmented cell injury in skin. Photochem Photobiol. 1991;53:757-762.
40. Lowe NJ, Wieder JM, Shorr N, Boxrud C, Saucer D, Chalet M. Infraorbital pigmented skin: preliminary observations of laser therapy. Dermatol Surg. 1995;21:767-770.
41. West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surg. 1998;24:615-616.
42. Collins P, Cotterill JA. Minocycline-induced pigmentation resolves after treatment with the Q-switched ruby laser. Br J Dermatol. 1996;135: 317-319.
43. Tsao H, Busam K, Barnhill RL, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. 1996;132:1250-1251.
44. Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol 1999;135:251-253.
45. Trotter MJ, Tron VA, Hollingdale J, Rivers JK. Localized chrysiasis induced by laser therapy. Arch Dermatol. 1995;131:1411-1414.
46. Anderson RR, Geronemus R, Kilmer SL, Farinelli W, Fitzpatrick RE. Cosmetic tattoo ink darkening: a complication of Q-switched and pulsed-laser treatment. Arch Dermatol. 1993;129:1010-1014.
47. Cohen HJ, Minkin W, Frank SB. Nevus spilus. Arch Dermatol. 1970;102:433-437.
48. Grevelink JM, Gonzalez S, Bonoan R, Vibhagool C, Gonzalez E. Treatment of nevus spilus with the Q-switched ruby laser. Dermatol Surg. 1997;23: 365-369.
49. Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol. 1993;32:908-912.
50. Bologna JL. Fatal melanoma arising in a zosteriform speckled lentiginous nevus. Arch Dermatol. 1991;127:1240-1241.
51. Kopera D, Hohenleutner U, Landthaler M.Quality-switched ruby laser treatment of solar lentigines and Beeker's nevus: a histopathological and immunochemical study. Dermatology. 1997;194: 338-343.
52. Formigon MM, Alsina M, Mascaro JM, Rivera F. Becker's nevus and ipsilateral breast hypoplasia: androgen-receptor study in two patients. Arch Dermatol. 1992;128:992-993.
53. Hohenleutner U, Landthailer M. Laser therapy of verrucous epidermal naevi. Clin Exp Dermatol. 1993;18:124-127.
54. Baba T, Narumi H, Hanada K, Hashimoto I. Successful treatment of dark-colored epidermal nevus with ruby laser. J Dermatol. 1995;22:567-570.
55. Kopera D. Treatment of lentigo maligna with the carbon dioxide laser. Arch Dermatol. 1995;131: 735-736.
56. Arndt KA. Argon treatment of lentigo maligna. J Am Acad Dermatol. 1984;10:953-957.
57. Kauvar AN, Geronemus RG. Treatment of lentigo maligna with a Q-switched ruby laser [abstract]. Lasers Surg Med Suppl. 1995;7:48.
58. Trau H, Orenstein A, Schewach-Miller M, Tsur H. Pseudomelanoma following laser therapy for congenital nevus. J Dermatol Surg Oncol. 1986;12: 984-986.
59. Waldorf HA, Kauvar AN, Geronemus RG. Treatment of small and medium congenital nevi with the Q-switched ruby laser. Arch Dermatol. 1996; 132:301-304.
60. Grevelink JM, van Leeuwen RL, Anderson RR, Byers HR. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol. 1997;133:349-353.
61. Rosenbach A, Williams CM, Alster TS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol Surg. 1997;23:239-244.
62. Imayama S, Ueda S. Long-and short-term histological observations of congenital nevi treated with the normal-mode ruby laser. Arch Dermatol. 1999;135:1211-1218.
63. Duke D, Byers R, Sober A, Anderson RR, Grevelink JM. Treatment of benign and atypical nevi with the normal mode ruby laser and the Q-switched ruby laser: clinical improvememt but failure to completely eliminate nevomelanocytes. Arch Dermatol. 1999;135:290-296.
64. van Leeuwen R, Dekker SK, Byers HR, Vermeer BJ, Grevelink JM. Modulation of alpha 4 beta 1 and alpha 5 beta 1 integrin expression: heterogeneous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melanoma cells in vitro. Lasers Surg Med. 1996;18:63-71.
65. Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.
66. Grevelink JM, Ross VE, Anderson RR. Lasers in dermatology. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill Co; 1999;2901-2921.